Scaling Beyond Digital-First Roots
Mumbai-based clean-label nutrition brand TruNativ has officially announced a $30 million funding round led by global healthcare investment giant OrbiMed Advisors. The capital injection, which features both primary and secondary share transactions, marks a significant growth milestone for the health-tech and D2C startup.
Strategic Growth Objectives
Founded in 2019 by Pranav and Mamta Malhotra, TruNativ has carved out a niche by offering transparent, nutritionally balanced food alternatives. The company intends to leverage this $30 million investment to achieve the following:
- Omnichannel Expansion: Deepening presence in physical retail outlets to complement its established e-commerce footprint.
- Portfolio Diversification: Scaling the product line to cater to broader consumer health requirements.
- Market Penetration: Accelerating growth initiatives across domestic and international target markets.
Investor Confidence and Market Trajectory
This round follows previous backing from notable names, including the Zerodha-backed firm Rainmatter, which invested ₹10 crore in late 2024. The involvement of a heavyweight institutional investor like OrbiMed underscores a rising investor appetite for brands that bridge the gap between wellness, transparency, and scalable consumer distribution.